Research Index
NMN (Nicotinamide Mononucleotide) Research Index
PSI surfaces 50 peer-reviewed studies on NMN (Nicotinamide Mononucleotide), prioritized by evidence strength: human clinical research first, then animal studies. The full historical archive is linked below on PubMed.
50 studies
Crystalline lens geometry from a clinical OCT-based biometer in pre-cataract surgery patients.
Rodriguez-Sanchez J, Ansah DO, de Castro A et al.
Res Sq·2026·Human·PubMed →
The Impact of Social Drivers of Health on Patient Portal Utilization for Total Joint Arthroplasty Patients: A Qualitative Study.
Antonioli SS, Alpert Z, Mishra S et al.
Arthroplast Today·2026·Human·PubMed →
Afamelanotide improves quality of life and light tolerance in Austrian erythropoietic protoporphyria patients.
Seidl-Philipp M, Schratter H, Auer J et al.
J Dtsch Dermatol Ges·2026·Human·PubMed →
Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study.
Shetty N, Quiñonez RL, Ceresnie MS et al.
Photochem Photobiol·2026·Human·PubMed →
Patient Portal Messaging to Care Teams Is Substantial and Associated With Emergency Department Visits and Hospital Readmission Following Elective Orthopedic Surgery.
Bernstein DN, Lucaciu AR, Detels K et al.
Orthopedics·2026·Human·PubMed →
Key role of Levitt's carbon monoxide breath test in revealing coexistent Gilbert syndrome and erythropoietic protoporphyria: A case report.
Kang LL, Zhang HD
World J Clin Cases·2026·Human·PubMed →
An open-label phase II study of bitopertin in adults and adolescents with erythropoietic protoporphyria or X-linked protoporphyria.
Ross G, Stewart P, Mensing G et al.
Clin Exp Dermatol·2026·Human·PubMed →
Mucosal immune responses to Bordetella pertussis in Gambian infants after maternal and primary vaccination: an immunological substudy of a single-centre, randomised, controlled, double-blind, phase 4 trial.
Saso A, Fröberg J, Jobe H et al.
Lancet Microbe·2026·Human·PubMed →
Assessing the Effects of eHealth Literacy and the Area Deprivation Index on Barriers to Electronic Patient Portal Use for Orthopedic Surgery: Cross-Sectional Observational Study.
Litvak AL, Lin N, Hynes K et al.
JMIR Perioper Med·2026·Human·PubMed →
Remission of erythropoietic protoporphyria (EPP) during pregnancy - Experience of two patients.
Paul G, Angelika H
J Dtsch Dermatol Ges·2026·Human·PubMed →
The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma.
Velotta JB, Roden AC, Rice J et al.
Ann Thorac Surg·2026·Animal·PubMed →
Combining Systems Thinking and Emotional Intelligence to Navigate Complexity in Simulation Debriefing.
Epp H, White BAA, Kardong-Edgren S et al.
Simul Healthc·2026·Animal·PubMed →
Adherencia a medidas de bioseguridad en la atención clínica en la Facultad de Odontología de la Universidad de Costa Rica.
Dittel Jiménez C, López Soto A, Boza Oreamuno Y
Arch Prev Riesgos Labor·2026·Animal·PubMed →
Extrusion-Free Survival Following Glaucoma Drainage Device Surgery Using EverPatch Plus(®): A Propensity Score-Weighted Survival Analysis.
Chihara E, Chihara T, Herndon LW Jr
J Clin Med·2026·Animal·PubMed →
Role of hemopexin in protoporphyrin IX distribution and cholestatic liver injury.
Gu R, Qin FY, Sun Z et al.
Toxicol Sci·2026·Animal·Liver Protection·PubMed →
Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications.
Schadt J, von Bonin M, Oelschlägel U et al.
Leukemia·2026·Animal·PubMed →
Entrainment effects and information processing in coupled oscillator models of auditory biomechanics.
Epp B, Rasmussen MB
Chaos·2026·Animal·PubMed →
Occupational Performance and Quality of Life in Individuals With Cardiovascular Conditions: A Cross-Sectional Study.
Jaber A, Alzoubi R, Rawashdeh S et al.
Occup Ther Int·2026·Animal·Cardiovascular Risk·PubMed →
Stress-induced plasminogen activator inhibitor-1 (PAI-1) as a blood biomarker and brain risk factor for PTSD.
Mennesson M, Abdelkaoui S, Roullot-Lacarrière V et al.
Mol Psychiatry·2026·Animal·PubMed →
Forced resilience: Indigenous perspectives on systemic barriers and humanizing genomic medicine in British Columbia, Canada.
Ehman M, Montour L, Pollard S et al.
Genet Med·2026·Animal·PubMed →
Construct Validity and Reliability of a Virtual Reality Cricket Batting Simulator.
Runswick OR, Phillips M, Morrone J et al.
Eur J Sport Sci·2026·Animal·PubMed →
Impact of long-term nitrogen scavenger therapy on clinical outcome in individuals with urea cycle disorders.
Posset R, Epp F, Garbade SF et al.
Sci Rep·2026·Animal·PubMed →
Agreement-Based Validation of ISOMETRO for Upper-Limb Isometric Tension Measurements.
González-Montesinos JL, Fernández-Santos JDR, Jiménez-Pavón D et al.
Sensors (Basel)·2026·Animal·Muscle Recovery·PubMed →
Polyphenolic Profile and Dietary Fiber Content of Skins and Seeds from Unfermented and Fermented Grape Pomace.
Guaita M, Zocco A, Messina S et al.
Molecules·2026·Animal·PubMed →
New pharmacotherapies for the erythropoietic protoporphyrias: an analysis of trial protocols from a patient perspective.
Dechant C, Wäscher S, Granata F et al.
Orphanet J Rare Dis·2025·Human·PubMed →
Neoadjuvant systemic therapy for pleural mesothelioma patients: a systematic review.
Smesseim I, Raskin J, Burgers JA
Transl Lung Cancer Res·2025·Human·PubMed →
Type of study: original study.
Chittabathina P, Gottumukkala SN, Penmetsa GS et al.
Lasers Med Sci·2025·Human·PubMed →
Enhancing Patient Satisfaction and Trust Through Electronic Patient Portals: Mediating Effects of Patient-Centered Communication and Self-Care Skills Among Chinese Deaf and Hard-Of-Hearing Patients.
Liu PL, Ye JF
J Health Commun·2025·Human·PubMed →
Burden of illness and unmet needs in patients with erythropoietic protoporphyria and X-linked protoporphyria: A large US nationwide claims analysis.
DerSarkissian M, Norregaard C, Romdhani H et al.
J Manag Care Spec Pharm·2025·Human·PubMed →
Challenges in the pathological diagnosis of erythropoietic protoporphyria: a case report.
Yang T, Chen C, Li C et al.
Front Med (Lausanne)·2025·Human·PubMed →
Artepillin C-rich propolis extract supplementation promotes muscle recovery following exercise-induced muscle damage in resistance-trained young females: a randomized, placebo-controlled trial.
Ramos Junior OJF, Veiga NS, Berretta AA et al.
J Int Soc Sports Nutr·2025·Human·PubMed →
Independent confirmation of the immunophenotypic ELN Scoring System in patients with MDS and CMML.
Oelschlaegel U, Schadt J, Epp K et al.
Hemasphere·2025·Human·PubMed →
Effectiveness of Adapted Physical Activity on Quality of Life of Patients with Knee and Hip Replacement: A Randomized Pilot Study.
Zinno R, Pinelli E, Barone G et al.
Healthcare (Basel)·2025·Human·PubMed →
Apitherapy with Royal Jelly and Green Propolis EPP-AF(®) Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis.
Kemp JA, Mendonça M, Chrispim P et al.
Toxins (Basel)·2025·Human·Cardiovascular Risk·PubMed →
Impact of delay in diagnosis in patients with erythropoietic protoporphyria: A cross-sectional survey study.
Tran B, Raef H, Rebeiz L et al.
JAAD Int·2025·Human·PubMed →
Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials.
Mateos MV, Trudel S, Quach H et al.
Blood Adv·2025·Human·PubMed →
Effectiveness of Surgical Treatment on Survival of Patients with Malignant Pleural Mesothelioma.
Báez-Saldaña R, Marmolejo-Torres ME, Iñiguez-García MA et al.
Cancers (Basel)·2025·Human·PubMed →
Second-Generation (44-Channel) Suprachoroidal Retinal Prosthesis: Surgical Stability and Safety During a 2-Year Clinical Trial.
Allen PJ, Kolic M, Baglin EK et al.
Clin Exp Ophthalmol·2025·Human·PubMed →
Erythropoietic protoporphyria linked to intricate double heterozygous mutations in theFECH gene: a case report and literature review.
Xiong H, He S, Yang Z et al.
Orphanet J Rare Dis·2025·Human·PubMed →
Smoking cue reactivity and smoking motives in patients with early phase psychotic disorder.
Couture ME, Stewart S, Barrett S et al.
Addict Behav·2025·Human·PubMed →
Metaresearch on patient-reported outcomes in trial protocols and results publications suggested large outcome reporting bias.
Taji Heravi A, Gryaznov D, Busse JW et al.
J Clin Epidemiol·2025·Human·PubMed →
Biological Variation of Erythrocyte Total, Metal-Free, and Zinc Protoporphyrin IX in Patients with Erythropoietic Protoporphyria and Healthy Subjects: Implications for Clinical Interpretation and Monitoring.
Lillemoen PKS, Fauskanger PK, Sandberg S et al.
Clin Chem·2025·Human·PubMed →
Effects of a Functional Food Mixture on Patients Undergoing Hemodialysis: Preliminary Results Highlighting the Modulation of Uremic Toxins Derived From Microbiota and Antioxidant Markers.
Nascimento D, Britto I, Couto H et al.
Mol Nutr Food Res·2025·Human·PubMed →
Neurodevelopmental Outcomes of Very Low Birth Weight Infants Following Extrauterine Placental Perfusion: A Follow-Up Study.
Kuehne B, Hellmich M, Heine E et al.
Acta Paediatr·2025·Human·PubMed →
Hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma after cytoreductive surgical procedures: a systematic review.
Elsayed HH, Elanany MEE, ElSayegh MT et al.
World J Surg Oncol·2025·Human·PubMed →
Connecting patients with clinical trials using patient navigation: a scoping review protocol.
Hilal O, Gupta P, Luginaah NA et al.
BMJ Open·2025·Human·PubMed →
German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP).
Homey B, Schelonke K, Schlegel CM et al.
Photodermatol Photoimmunol Photomed·2025·Human·PubMed →
Case Report: Cholestatic liver disease in the course of erythropoietic protoporphyria associated with renal hypodysplasia and atrial septal defect.
Lipiński P, Lipniacka A, Klaudel-Dreszler M et al.
Front Pediatr·2025·Human·PubMed →
Acute Intermittent Hypoxia in People Living With Chronic Stroke: A Case Series.
Pearcey GEP, Barry AJ, Sandhu MS et al.
Stroke·2025·Human·PubMed →
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Mayne KJ, Sardell RJ, Staplin N et al.
Clin J Am Soc Nephrol·2024·Human·PubMed →